Category: Syk Kinase

  • Background To investigate prognosis and effects of first-line therapy in seniors

    Background To investigate prognosis and effects of first-line therapy in seniors primary central nervous system lymphoma (PCNSL) individuals. HD-MTX plus oral chemotherapy and more aggressive HD-MTX-based therapies (HR 1.39, 95% CI 0.90C2.15). Radiotherapy was associated with an improved survival, but correlated with an increased risk for neurological side-effects (odds percentage 5.23, 95% CI 2.33C11.74). Conclusions…